AMETEK announced record financial results for the third quarter ended September 30, 2026, featuring sales of $2.22 billion and adjusted diluted earnings of $2.21 per share. Driven by strong operational performance and the acquisition of Indicor Instrumentation, the company raised its full-year 2026 adjusted earnings guidance to a range of $8.53 to $8.57 per share.
Third quarter sales reached a record $2.22 billion, a 17% increase compared to the third quarter of 2025.
Adjusted diluted earnings per share for the third quarter rose 17% year-over-year to a record $2.21.
Full-year 2026 adjusted earnings guidance was increased to a range of $8.53 to $8.57 per share, up from the prior range of $8.20 to $8.30.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Ametek's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$7.40B
+6.6%
$6.40
+7.9%
20.0%
FY2024
$6.94B
+5.2%
$5.93
+4.6%
19.8%
FY2023
$6.60B
+7.3%
$5.67
+13.2%
19.9%
FY2022
$6.15B
+10.9%
$5.01
+17.9%
18.9%
FY2021
$5.55B
+22.2%
$4.25
+12.7%
17.9%
Frequently asked questions
When is Ametek's next earnings date?
Ametek has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Ametek earn last quarter?
For the quarter ended Sep 2026, Ametek reported diluted EPS of $1.85 (+15.6% year over year) on revenue of $2.22B (+17.3%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.